•
Dec 31, 2024

ALX Oncology Q4 2024 Earnings Report

Total Revenue
$0
0
EPS
-$0.44
Previous year: -$0.79
-44.3%
Gross Profit
-$214K
0
Cash and Equivalents
$128M
Previous year: $218M
-41.4%
Free Cash Flow
-$32.1M
Previous year: -$39.8M
-19.4%
Total Assets
$148M
Previous year: $243M
-39.1%

ALX Oncology

ALX Oncology